These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12042205)

  • 21. Safety of antipsychotics in the setting of QTc prolongation: the utility of the JT index.
    Mukherji EH; Bauer LK; Leskov I; Januzzi JL; Tanev KS
    Am J Psychiatry; 2011 Sep; 168(9):990-1. PubMed ID: 21890808
    [No Abstract]   [Full Text] [Related]  

  • 22. Long-term efficacy and tolerability of clozapine combined with ziprasidone or risperidone.
    Kuwilsky A; Krumm B; Englisch S; Dressing H; Zink M
    Pharmacopsychiatry; 2010 Aug; 43(6):216-20. PubMed ID: 20589598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antipsychotics and QT prolongation.
    Taylor DM
    Acta Psychiatr Scand; 2003 Feb; 107(2):85-95. PubMed ID: 12534433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement in QTc prolongation induced by zotepine following a switch to perospirone.
    Suzuki Y; Watanabe J; Sugai T; Fukui N; Ono S; Tsuneyama N; Saito M; Someya T
    Psychiatry Clin Neurosci; 2012 Apr; 66(3):244. PubMed ID: 22443250
    [No Abstract]   [Full Text] [Related]  

  • 25. Early bicarbonate loading and dantroline for ziprasidone/haloperidol-induced neuroleptic malignant syndrome.
    Strawn JR; Keck PE
    J Clin Psychiatry; 2006 Apr; 67(4):677. PubMed ID: 16669738
    [No Abstract]   [Full Text] [Related]  

  • 26. QT interval--what is normal? Comment on "single-dose ziprasidone associated with QT interval prolongation".
    Sanaei-Zadeh H
    Am J Emerg Med; 2012 May; 30(4):627. PubMed ID: 22306388
    [No Abstract]   [Full Text] [Related]  

  • 27. Mechanisms and risks of electrocardiographic QT interval prolongation when using antipsychotic drugs.
    Vieweg WV
    J Clin Psychiatry; 2002; 63 Suppl 9():18-24. PubMed ID: 12088172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Priapism associated with two atypical antipsychotic agents.
    Reeves RR; Mack JE
    Pharmacotherapy; 2002 Aug; 22(8):1070-3. PubMed ID: 12173794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrocardiographic changes with ziprasidone.
    Loebel A; Miceli J; Chappell P; Siu C
    J Am Acad Child Adolesc Psychiatry; 2006 Jun; 45(6):636-637. PubMed ID: 16721311
    [No Abstract]   [Full Text] [Related]  

  • 30. Side effects of ziprasidone.
    Teich J
    Am J Psychiatry; 2003 Jul; 160(7):1355-6. PubMed ID: 12832258
    [No Abstract]   [Full Text] [Related]  

  • 31. Inadvertent administration of intravenous ziprasidone leading to bradycardia and QT interval prolongation.
    Bentley ML; Biscardi FH; Butcher C; Levitov A
    Ann Pharmacother; 2008 Jun; 42(6):902-3. PubMed ID: 18477728
    [No Abstract]   [Full Text] [Related]  

  • 32. A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition.
    Harrigan EP; Miceli JJ; Anziano R; Watsky E; Reeves KR; Cutler NR; Sramek J; Shiovitz T; Middle M
    J Clin Psychopharmacol; 2004 Feb; 24(1):62-9. PubMed ID: 14709949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Asymptomatic QTc prolongation during coadministration of aripiprazole and haloperidol.
    Leo R; Razzini C; Di Lorenzo G; Bianchi F; Tesauro M; Zanasi M; Siracusano A; Romeo F
    J Clin Psychiatry; 2008 Feb; 69(2):327-8. PubMed ID: 18363460
    [No Abstract]   [Full Text] [Related]  

  • 34. Experience with ziprasidone.
    Patel NC; Sierk P; Dorson PG; Crismon L
    J Am Acad Child Adolesc Psychiatry; 2002 May; 41(5):495. PubMed ID: 12014778
    [No Abstract]   [Full Text] [Related]  

  • 35. Antipsychotic medications and cardiac conduction risks.
    Roman M; Farmer SY
    Issues Ment Health Nurs; 2010 Jan; 31(1):68-70. PubMed ID: 19951166
    [No Abstract]   [Full Text] [Related]  

  • 36. QT prolongation of the antipsychotic risperidone is predominantly related to its 9-hydroxy metabolite paliperidone.
    Suzuki Y; Fukui N; Watanabe J; Ono S; Sugai T; Tsuneyama N; Saito M; Inoue Y; Someya T
    Hum Psychopharmacol; 2012 Jan; 27(1):39-42. PubMed ID: 22144033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Risperidone use in child and adolescent psychiatric patients].
    Chevreuil C; Reymann JM; Frémaux T; Polard E; Séveno T; Bentué-Ferrer D
    Therapie; 2008; 63(5):359-75. PubMed ID: 19154706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolactin elevation with ziprasidone.
    Lusskin SI; Cancro R; Chuang L; Jacobson J
    Am J Psychiatry; 2004 Oct; 161(10):1925. PubMed ID: 15465997
    [No Abstract]   [Full Text] [Related]  

  • 39. Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: a review of the literature.
    Lawrence KR; Nasraway SA
    Pharmacotherapy; 1997; 17(3):531-7. PubMed ID: 9165555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Torsades de pointes associated with ziprasidone.
    Heinrich TW; Biblo LA; Schneider J
    Psychosomatics; 2006; 47(3):264-8. PubMed ID: 16684946
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.